| (210) | Number of the EPO application | 17738831 |
| (220) | Filing date of the EPO application | 2017.01.11 |
| (80) | EPO patent specification publication (B) | EPB nr. 15/2022, 2022.04.13 |
| (110) | EPO patent number | 3402532 |
| (21) | Number of the application | e 2018 1127 |
| (71) | Name(s) of applicant(s), code of the country | Celator Pharmaceuticals, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | DRUMMOND Daryl C., US;
GENG Bolin, US;
KIRPOTIN Dmitri B., US;
TIPPARAJU Suresh K., US;
KOSHKARYEV Alexander, US;
ALKAN Ozan, US; |
| (73) | Name(s) of owner(s), code of the country | Celator Pharmaceuticals, Inc., US; |
| (54) | Title of the invention | INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR) |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 48/00 (2006.01.01); A61K 31/4745 (2006.01.01); A61K 31/7068 (2006.01.01); A61K 31/555 (2006.01.01); A61K 9/127 (2006.01.01); A61K 31/496 (2006.01.01); A61K 31/4965 (2006.01.01); A61K 31/497 (2006.01.01); C07D 403/12 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.01.31 |
| (30) | Priority | 201662277262 P, 2016.01.11, US; 201662420258 P, 2016.11.10, US; 201762444172 P, 2017.01.09, US |
| (86) | International application | PCT/US2017/012939, 2017.01.11 |
| (87) | International publication | WO 2017/123588, 2017.07.20 |